CHINA Trends and Developments
Trends and Developments Contributed by: Hanshuo Zhou, Xiaoyun Wang and Taige Shi (Casper) Jingtian & Gongcheng Jingtian & Gongcheng is one of the earliest established private partnership law firms in the PRC, with offices in Beijing, Shanghai, and seven other major cities nationwide. Its health- care and life sciences practice is led by a core team of eight lawyers with extensive experience across the pharmaceutical, biotechnology, and medical device sectors, advising on both regu- latory and transactional matters. The team has developed particular strength in digital health, including issues related to data privacy com- pliance, cross-border data flows, cloud-based infrastructure, and the regulatory structuring of telemedicine and AI-enabled diagnostic tech- nologies. The practice provides end-to-end
legal support to a wide range of industry par- ticipants, including technology companies en- tering the healthcare space, established phar- maceutical manufacturers, biotech ventures, and digital health platforms. Recent mandates include advising on venture financing in health- care innovation, negotiating licensing and R&D collaborations, supporting cross-border data transfer compliance for licence-in projects, and supporting the deployment of telemedicine and AI-driven health solutions within China’s evolv- ing compliance landscape. The firm would like to acknowledge the contri- bution of the Shanghai Office’s intern Yiwei Lu (Will) to this article.
Authors
Hanshuo Zhou is a partner at Jingtian & Gongcheng with over a decade of legal experience in both private practice and
Xiaoyun Wang is a partner at Jingtian & Gongcheng, specialising in life sciences and healthcare, and has over ten years of experience. He focuses on PE/VC investments (including
in-house roles. She specialises in private equity, venture capital, M&A, compliance, and investigations, with a particular focus on the life sciences and healthcare sector. Ms Zhou is licensed to practice in China and New York, and regularly advises multinational clients on cross-border transactions and localised compliance frameworks. She holds LLM degrees from East China University of Political Science and Law and the University of Texas at Austin. She has been ranked in the Chambers Greater China Region Guide (Healthcare) since 2024 and is also a Program Professor at a business school.
cross-border Newco structures), M&A, digital healthcare compliance and complex licensing (in/out) transactions for multinationals, biotechs, and US/RMB funds. He specialises in integrated legal service delivery, combining strategic advisory with hands-on execution for PE/VC, licensing, and compliance matters, ensuring operational readiness at every stage.
37
CHAMBERS.COM
Powered by FlippingBook